title: Physiological aspects of cardiac tissue engineering.
abstract: Cardiac tissue engineering aims at repairing the diseased heart and developing cardiac tissues for basic research and predictive toxicology applications. Since the first description of engineered heart tissue 15 years ago, major development steps were directed toward these three goals. Technical innovations led to improved three-dimensional cardiac tissue structure and near physiological contractile force development. Automation and standardization allow medium throughput screening. Larger constructs composed of many small engineered heart tissues or stacked cell sheet tissues were tested for cardiac repair and were associated with functional improvements in rats. Whether these approaches can be simply transferred to larger animals or the human patients remains to be tested. The availability of an unrestricted human cardiac myocyte cell source from human embryonic stem cells or human-induced pluripotent stem cells is a major breakthrough. This review summarizes current tissue engineering techniques with their strengths and limitations and possible future applications.
authors.affiliation: Department of Experimental Pharmacology and Toxicology, Cardiovascular Research Center Hamburg, University Medical Center Hamburg Eppendorf, Hamburg, Germany. t.eschenhagen@uke.de
authors.forename: Thomas
authors.initials: T
authors.lastname: Eschenhagen
authors.forename: Alexandra
authors.initials: A
authors.lastname: Eder
authors.forename: Ingra
authors.initials: I
authors.lastname: Vollert
authors.forename: Arne
authors.initials: A
authors.lastname: Hansen
mesh_terms: D000818:Animals; D053595:Embryonic Stem Cells / Q000502:physiology; D006321:Heart / Q000502:physiology*; D006331:Heart Diseases / Q000628:therapy*; D006801:Humans; D051379:Mice; D039904:Pluripotent Stem Cells / Q000502:physiology; D051381:Rats; D023822:Tissue Engineering / Q000379:methods*